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ABSTRACT Hepatitis C virus (HCV) and human pegivirus (HPgV or GB virus C) are globally distributed and infect 2 to 5% of the
human population. The lack of tractable-animal models for these viruses, in particular for HCV, has hampered the study of in-
fection, transmission, virulence, immunity, and pathogenesis. To address this challenge, we searched for homologous viruses in
small mammals, including wild rodents. Here we report the discovery of several new hepaciviruses (HCV-like viruses) and pegi-
viruses (GB virus-like viruses) that infect wild rodents. Complete genome sequences were acquired for a rodent hepacivirus
(RHV) found in Peromyscus maniculatus and a rodent pegivirus (RPgV) found inNeotoma albigula. Unique genomic features
and phylogenetic analyses confirmed that these RHV and RPgV variants represent several novel virus species in theHepacivirus
and Pegivirus genera within the family Flaviviridae. The genetic diversity of the rodent hepaciviruses exceeded that observed for
hepaciviruses infecting either humans or non-primates, leading to new insights into the origin, evolution, and host range of
hepaciviruses. The presence of genes, encoded proteins, and translation elements homologous to those found in human hepaci-
viruses and pegiviruses suggests the potential for the development of new animal systems with which to model HCV pathogene-
sis, vaccine design, and treatment.
IMPORTANCE The genetic and biological characterization of animal homologs of human viruses provides insights into the origins
of human infections and enhances our ability to study their pathogenesis and explore preventive and therapeutic interventions.
Horses are the only reported host of nonprimate homologs of hepatitis C virus (HCV). Here, we report the discovery of HCV-
like viruses in wild rodents. The majority of HCV-like viruses were found in deer mice (Peromyscus maniculatus), a small rodent
used in laboratories to study viruses, including hantaviruses. We also identified pegiviruses in rodents that are distinct from the
pegiviruses found in primates, bats, and horses. These novel viruses may enable the development of small-animal models for
HCV, the most common infectious cause of liver failure and hepatocellular carcinoma after hepatitis B virus, and help to explore
the health relevance of the highly prevalent human pegiviruses.
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Hepatitis C virus (HCV) and human pegiviruses (HPgVs) in-fect an estimated 2% and 5% of the world’s population, re-
spectively. HCV, HPgV (formerly referred to as GB virus C
[GBV-C] or hepatitis G virus), and other genetically related vi-
ruses belong to two genera in the Flaviviridae family, Hepacivirus
and Pegivirus, respectively (1). HCV is hepatotropic and can trig-
ger liver damage characterized by fibrosis, cirrhosis, and hepato-
cellular carcinoma (2). HPgV is lymphotropic (3), but its patho-
genicity for humans, if any, is unknown. HPgV is more prevalent
in people with blood-borne or sexually transmitted infections
than in the general population. Up to 40% of HIV-infected indi-
viduals have HPgV viremia (1, 4, 5). Viruses genetically most sim-
ilar to human HCV include GBV-B and the recently discovered
nonprimate hepaciviruses (NPHVs) (6). These viruses show ex-
tensive gene homology and conserved genomic elements with
HCV, as well as genus-specific features (1) that include a core
protein, a type IV internal ribosomal entry site (IRES), and hepa-
totropism. Horses are the natural host for NPHVs (6, 7). The
origin and natural host of GBV-B are unknown. Pegiviruses infect
a wide range of mammals, including chimpanzees, New World
primates (GBV-A or simian PgV [SPgV]), horses (equine PgV
[EPgV] [A. Kapoor, et al., submitted for publication]), and bats
(GBV-D or bat PgV [BPgV]) (1, 8, 9).
Despite differences in their pathogenic potentials, HCV and
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HPgVs share many biological properties, including similar struc-
tural and genomic organizations, high inter- and intrahost genetic
diversity, and, frequently, persistent infection of their natural
hosts. Studies of HCV and HPgV in nonhuman primates have led
to important advances in our understanding of their biology and
pathogenesis (1, 10–13). However, basic questions regarding vir-
ulence determinants, organ tropism, systemic host responses, vi-
ral dynamics, and mechanisms of disease induction remain unan-
swered (10, 14). The currently characterized hepaciviruses and
pegiviruses have narrow host ranges. HCV infects only humans
and chimpanzees. Pegiviruses infecting humans, Old World pri-
mates, and New World primates are species-specific. Small-
animal models often supply the extensive genetic and immuno-
logic tools required to evaluate viral pathogenesis and immunity.
The lack of such a model has impeded research on this important
group of viruses (10). To address this challenge, we initiated a
methodical search for such viruses in several species of wild ro-
dents.
RESULTS
Identification and genetic characterization of new rodent vi-
ruses. Plasma samples of 400 wild-caught rodents, predomi-
nantly deer mice, were screened using two degenerate sets of
primers targeting conserved virus helicase motifs of hepaciviruses
and PgVs. Sequencing of PCR products confirmed the presence of
hepaciviruses and PgVs in 18 samples of rodents belonging to four
species: hispid pocket mice (Chaetodipus hispidus), deer mice
(Peromyscusmaniculatus), desert wood rats (Neotoma lepida), and
white-throated wood rats (Neotoma albigula). The majority of
samples were from these rodent species, which may have induced
sampling bias. Although the sequencing of PCR products pro-
vided only 300-nucleotide (nt)-long viral fragments, the highly
conserved nature of the sequenced helicase region allowed accu-
rate phylogenetic classification of all new viruses (Fig. 1). Appro-
priate classification of well-characterized viruses using the corre-
sponding sequence region validated our analysis (1, 6, 7).
Moreover, the phylogenetic tree constructed with the complete
protein sequences of new rodent viruses shows clustering concor-
dant with that obtained using partial helicase sequences (Fig. 1
and 2). Following the International Committee for Taxonomy of
Viruses guidelines of using host names to describe hepaciviruses
and pegiviruses (1, 6, 7), we tentatively named these new viruses
rodent hepacivirus (RHV) and rodent pegivirus (RPgV). We re-
frained from naming viruses on the basis of host species, given that
their natural host and species tropism requires further investiga-
tion (7).
Despite their high genetic diversity, all new rodent virus se-
quences fell into the hepacivirus or pegivirus clade, supporting
their provisional assignment to these genera of the family Flavi-
viridae (1). Based on the phylogenetic analyses of partial helicase
sequences and intraspecies genetic distances of known viruses
(HCV and NPHV), the RHV sequences identified in our study can
be tentatively classified as five new virus species. Of these, three
new RHV species were found in a single host species, deer mice.
Two new RHV species were found in desert wood rats and hispid
pocket mice. Despite our limited sampling of host animals, one of
the new RHV species showed intraspecies genetic diversity (RHV-
pm4144, RHV-pm4062, RHV-pm3243, RHV-pm3252, RHV-
pm5198, RHV-pm4109, and RHV-pm5263) that was equivalent
to that reported among different HCV subtypes (Fig. 1). Our anal-
ysis also showed that the observed genetic diversity of RHV species
exceeded that reported for all known hepaciviruses. The natural
host of GBV-B remains obscure, and noticeably, GBV-B fell
within the genetic diversity of RHV species.
We found two new species of pegiviruses in rodents, one in
white-throated wood rats (RPgV-cc61) and the other in deer mice
(RPgV-pm5226, RPgV-pm6197, RPgV-pm6073, RPgV-pm6041,
and RPgV-pm6087). All of the 5 RPgV variants found in deer mice
clustered together, indicating a single genetically diverse RPgV
species (Fig. 1). The latter variants from deer mice clustered to-
gether, with divergence between different variants comparable to
the diversity observed between genotypes of human pegiviruses
(Fig. 1).
Genetic analysis of rodent RHVs. We acquired the complete
genome of RHV-339 (8,879 nt) and the nearly complete genome
of RHV-089 (8,252 nt), which were found in plasma samples of
two different deer mice. As with HCV, the RHV genome is pre-
dicted to encode a long polyprotein flanked by 5= and 3= untrans-
lated regions (UTRs). In the open reading frame (ORF), 8% syn-
onymous (dS) and1% nonsynonymous (dN) mutations existed
between the genomes of the two variants, indicative of strong pu-
rifying selection. The first in-frame polyprotein initiation codon
was found at nucleotide position 403 of the RHV-339 genome and
at the corresponding position in RHV-089. Although the pro-
posed start codon did not include a classical Kozak consensus
sequence (ccaCttATGG), an even-less-favorable Kozak context is
found in GBV-B (tagCaaATGC) (where lowercase bases indicate
variable positions), consistent with ribosomal positioning and
translation initiation by a type IV internal ribosome entry site
(IRES). The 5= UTR region of RHV-089 and the corresponding
region of RHV-339 showed homology to other hepacivirus se-
quences in the 200-nt region adjacent to the start of the polypro-
tein initiation codon (Fig. 3). The remaining 5= UTR returned no
matches from BLAST searching against the full GenBank se-
quence database, although a miR-122 seed site (UACACUCC)
was found in the RHV-339 5= UTR at nt 7 to 14, which may
indicate the hepatotropic potential of these rodent hepaciviruses.
Although convincing alignments on which to base structure pre-
dictions could not be achieved, the positioning and occurrence of
covariant changes in sequences homologous to those of other
hepaciviruses allowed us to establish a partial structural model of
the IRES in the region corresponding to domain III of the type IV
HCV IRES, which included each of the IIIa to IIIf stem-loops and
the pseudoknot (IIIf) region sequences (Fig. 3). The region 5= to
the start of stem-loop III was shorter than corresponding se-
quences of HCV, GBV-B, and NPHV. Downstream of the poly-
protein stop codon, we identified a 3= UTR of 230 nt consisting of
a structured region, potentially equivalent to the HCV 3= variable
region, a poly(C) tract of around 10 nt, and a 3= X region of 158 nt,
which is predicted to fold into 4 stem-loop structures (Fig. 3B).
The structural elements of the 3= UTR resembled those of HCV,
with a short poly(C) tract replacing the long HCV poly(U/C) tract,
and a longer 3= X region. The RHV 3= UTR shared no sequence
homology with HCV or other database sequences.
The RHV open reading frame is predicted to encode a polypro-
tein of 2,748 amino acids (aa), shorter than those of HCV-1a
(3,011 aa), NPHV (2,942 aa), and GBV-B (2,854 aa). Comparative
genetic analysis predicts that the RHV-339 polyprotein contains
three structural (core, E1, E2) and seven nonstructural (NS) (p7,
NS2, NS3, NS4A, NS4B, NS5A, and NS5B) proteins (Fig. 4).
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Cleavage sites in the RHV polyprotein and in other hepaciviruses
were predicted by alignment and homology to sites previously
identified in HCV (15). Because of sequence variability around
cleavage sites in structural proteins, the motifs for RHV and
NPHV were independently predicted using the SignalP 4.1 server
(16) and inferred from the cleavage motifs that aligned with those
in HCV. Structural and nonstructural RHV proteins were similar
in predicted size to those of HCV and other hepaciviruses
(Fig. 4C), including a predicted 63-aa p7 transmembrane protein
(Fig. 4C). However, the core protein was shorter than for HCV
(168 versus 191 aa), as was E2 (279 versus 383 aa). The E1 and E2
proteins contained 2 and 4 predicted N-linked glycosylation sites,
respectively, fewer than those found in the homologous glycopro-
teins of HCV (6 and 11, respectively), NPHV (4 and 10, respec-
tively), and GBV-B (3 and 6, respectively). The region encoding
the putative core protein lacked an alternative open reading frame
equivalent to the proposed HCV alternative reading frame protein
(17).
Despite the similarity in organization and structural features in
the hepacivirus genomes, sequences were extraordinarily diver-
gent from each other at the nucleotide and amino acid levels.
Coding sequences were aligned, and pairwise distances between
FIG 1 Phylogenetic analysis of new rodent viruses using the partial helicase sequences generated by generic PCR. Bootstrap resampling was used to determine
the robustness of branches; values of70% (from 1,000 replicates) are shown. Host origins of newly reported viral sequences are indicated by red and yellow
circles (see the key) and for previously described hepaciviruses (blue circles) and pegiviruses (green circles).
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structural and nonstructural genome regions were computed (Ta-
ble 1). RHV-339 showed mean amino acid divergences ranging
from 67% to 77% in the structural region and from 65% to 70% in
the NS regions, similar to the divergences between HCV and
GBV-B and substantially greater than those between HCV and
NPHV. Genetic divergence between the entire genome of RHV-
339 and the known hepaciviruses (HCV, GBV-B, and NPHV) was
analyzed using a scanning window of 300 nt in 15-nt increments
(Fig. 4). As observed for NPHV (6, 7), the most-conserved regions
within viruses of the Hepacivirus genus were the NS3 and NS5B
genes. High sequence divergence was observed in the E1 and E2
glycoproteins and NS4B; there was no apparent homology to
other sequences in GenBank in extended regions of NS4A and
NS5A. Sequence comparisons were extended to include homolo-
gous sequences from the other members of the Flaviviridae lo-
cated in the NS3 and NS5B regions, and these sequences could be
aligned (Fig. 2). Phylogenetic trees from the two genomic regions
were topologically equivalent but different in relative branch
lengths. The analysis confirmed the separate grouping of RHV-
339 and RHV-89 from all other hepaciviruses (Fig. 2A and B),
although hepaciviruses collectively formed a separate bootstrap
that differentiated them from pegiviruses. RNA folding analysis of
the RHV genome revealed that the minimum folding energy dif-
ference (MFED) value of RHV was 4.6%, which is well below the 8
to 9% determined for HCV and 9% for GBV-B. This suggested a
less structured RHV genome.
Genetic analysis of rodent pegivirus. The complete genome
(11,279 nt) of the rodent pegivirus (RPgV-cc61) found in a white-
throated wood rat included a 5= UTR (349 nt), a polyprotein cod-
ing region (10,452 nt; 3,484 aa) and a 3= UTR (475 nt). The RPgV-
cc61 5= UTR showed no significant similarity with any known
pegivirus sequence; therefore, prediction of its secondary RNA
structure was problematic in the absence of a structural alignment
or covariance data. The first initiating codon in frame with the
predicted encoded polyprotein was located at position 350. The 3=
UTR sequence contained two internal poly(C) tracts of around
9 nt, and stable stem-loop structures could be predicted immedi-
ately downstream of the stop codon and at the very 3= end of the
genome (Fig. 3C). Surprisingly, two repeat sequence elements
(RSEs), potentially folding into similar stem-loop structures, were
exact copies of a 24-nt region from the 5= UTRs of human entero-
virus, coxsackievirus, echovirus, and swine vesicular disease virus.
No other homology to known viral sequences was found in the
RPgV 3= UTR.
Cleavage sites in the RPgV polyprotein were predicted by align-
ment and homology to sites previously predicted between non-
structural proteins in simian and bat pegiviruses (GBV-A [18];
GBV-D [8]; sites NS3/NS4A, NS4A/NS4B, NS4B/NS5A, and
NS5A/NS5B) and by comparison to predicted signalase sites be-
tween structural proteins of RPgV and other pegiviruses. This
analysis identified homologous cleavage sites that aligned with
those in BPgV, including the boundaries of the proposed novel X
protein (Fig. 5). Our analysis indicated that the RPgV-cc61 ge-
nome might harbor an additional signalase site after nt 1015 and
before a coding sequence that was clearly homologous to E1 of
other pegiviruses. The presence of a hydrophobic sequence of
FIG 2 Phylogenetic analysis of conserved regions in the helicase (motifs I to VI) (A) and RdRp (B) genes of rodent hepaciviruses and pegiviruses aligned with
representative members of the Hepacivirus, Pegivirus, Pestivirus, and Flavivirus genera. Trees were constructed by neighbor joining of pairwise amino acid
distances with the program MEGA5 (according to the distance scale provided). Bootstrap resampling was used to determine the robustness of branches; values
of70% (from 1,000 replicates) are shown. Regions compared corresponded to positions 3667 to 4470 (helicase domain of NS3) and 7711 to 8550 (RdRp in
NS5B; numbered according to the AF011751 HCV genotype 1a reference sequence).
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31 aa at the beginning of the polyprotein possibly functions as a
signal peptide that leads to translocation of a predicted 223-aa
protein (labeled “Y” in Fig. 5) into the endoplasmic reticulum
(ER) (which is analogous to E1 processing for other pegiviruses).
The presence of two N-linked glycosylation sites in this coding
sequence suggests a possible fourth glycoprotein (in addition to
E1, E2, and X) in the RPgV envelope. Alignment of the RPgV
sequence with simian and bat pegiviruses allowed prediction of
cleavage sites of the nonstructural proteins NS2, NS3, NS4A,
NS4B, NS5A, and NS5B. Each was comparable in size to homologs
from other pegiviruses.
The genetic relatedness of RPgV-cc61 to other pegiviruses was
assessed by alignment of coding sequences and calculations of
pairwise distances between structural and nonstructural genome
regions (Table 2). RPgV-cc61 was substantially divergent from
HPgV, SPgV, BPgV, and EPgV sequences, with amino acid diver-
gence ranging from 78% to 81% in the structural proteins and
54% to 56% in the NS region (Table 2). The degree of genetic
divergence across the genome of RPgV-cc61 from those of other
pegiviruses was analyzed as described for RHV (Fig. 5). Consis-
tently with previous analyses (6, 7), the most-conserved regions
within viruses of the genus Pegivirus were the NS3 and NS5B
genes, with high sequence divergence in the E1 and E2 glycopro-
teins and NS4B and no apparent homology to other sequences in
GenBank in extended regions of X, NS4A, and NS5A (Fig. 5).
Phylogenetic analysis of the NS3 and NS5B regions confirmed the
separate grouping of RPgV-cc61 from all other pegiviruses
(Fig. 2A and B). RNA folding analysis of the RPgV genome re-
vealed that the MFED value of the RPgV genome was 9.7%, an
observation consistent with the presence of a genome-scale, or-
dered RNA structure (7). This MFED value was similar to those of
human (mean, 12.8% [11.7% to 13.3%]), simian (mean, 13.3%
[12.7% to 13.8%]), bat (9.7% and 10.7%), and equine (10.7%)
pegiviruses (6).
DISCUSSION
The identification and characterization of animal virus homologs
can provide insights into the pathogenesis of human viruses and,
FIG3 Predicted structures in the RHV-339 and RPgV-cc61 UTRs. (A) RHV-339 5= UTR structure predictions were made by homology searching and structural
alignment within domain III. Bases conserved in all hepaciviruses (HCV, NPHV, and GBV-B) are highlighted with blue circles. (B) Structure prediction of the
RHV 3= UTR using Mfold. The ORF stop codon is boxed, and a putative variable region equivalent to that of HCV is indicated. A poly(C) tract of around 10 nt
separates this from the downstream 3= X region, which was predicted to fold into four stem-loops (3=SL1 to -4). (C) Predicted structure of the RPgV 3= UTR. The
black bar cartoon of the 3= UTR (475 nt) was drawn to scale, with poly(C) tracts indicated in blue. Strong stem-loop structures immediately downstream of the
ORF stop codon (boxed) and at the very end of the genome are indicated. RSEs, potentially folding into similar stem-loop structures, are outlined in red. The
structure prediction of the RPgV 3= UTR was done using Mfold.
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in some instances, in vivomodels for investigating methods for the
prevention and treatment of human disease (19). Examples where
well-characterized animal viruses have provided such insights in-
clude simian immunodeficiency virus, animal poxviruses, herpes-
viruses, murine norovirus, and woodchuck hepatitis virus (20).
HCV, in contrast, has no satisfactory homolog (6, 21), and only
chimpanzees can be experimentally infected with HCV (22–25).
Even before the recent U.S. Institute of Medicine recommenda-
tions to restrict the use of chimpanzees for biomedical research,
limited access to these animals was a challenge for HCV research.
NPHV and GBV-B are the most genetically similar to HCV (6)
and could therefore be used as surrogate models of HCV infection.
The natural host of NPHV is the horse (6, 7, 17), in which high
frequencies of viremia (from 3 to 8%) have been reported in sep-
arate studies (17). GBV-B was initially detected in a laboratory
tamarin (New World monkeys of the family Callitrichidae). How-
ever, subsequent attempts to identify its natural host that concen-
trated primarily on the screening of New World primates have
been unsuccessful. Nonetheless, GBV-B-infected tamarins and
marmosets have been used as surrogate models for HCV patho-
genesis. The identification of rodent hepaciviruses may finally
provide a promising small-animal model for the study of hepaci-
viruses, with possible relevance to HCV.
Here we identified several lineages of RHV in deer mice that are
as highly divergent from each other as are HCV and GBV-B. In
light of the recent finding of hepaciviruses infecting horses and
dogs (6, 7, 17), which are considerably more similar to HCV than
GBV-B or RHV, it is unlikely that hepaciviruses coevolved with
their hosts. The basal radiation of three different lineages of hepa-
civiruses infecting deer mice (Fig. 1) means either that the variants
FIG 4 (A) Amino acid sequence divergence between RHV and human virus (HCV), equine virus (NPHV), and GBV-B using 300-nt fragments by 15-nt
increments across the sequence alignment (the midpoint is plotted on the y axis). Within-species distances for human and equine hepaciviruses are included for
comparison. (B, C) Genome diagram of RHV showing predicted N-linked glycosylation sites (downward-pointing arrows) and proposed cleavage sites of cellular
peptidase (black triangles), NS2-3 protease (white triangle), and NS3-4A protease (gray triangles) (sequence positions were numbered using the RHV sequence).
Kapoor et al.
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diversified within this host species and subsequently infected an-
other rodent species (Neotoma lepida) and ultimately a tamarin
(GBV-B) or that deer mice became infected with highly genetically
distinct hepaciviruses from other host species. Either explanation
requires the occurrence of multiple cross-species events that can-
not be dated a priori. Thus, without a chronological anchor, we
did not attempt to estimate the evolutionary rates of hepacivirus
lineages and their divergence times. The hepaciviruses identified
by us in this and previous studies (7) may have cross-species trans-
mission potential. The high genetic diversity observed among
RHV species raises the possibility that hepaciviruses (HCV,
NPHV, and GBV-B) may have actually originated in rodents.
Serology-enabled approaches, such as the one we recently used to
study the host tropism of NPHV (7), will be very useful in deter-
mining the host range and cross-species transmission potential of
these novel rodent viruses and in identifying related viruses that
infect other animal species.
Viruses genetically related to HPgV include its primate ho-
mologs (SPgV), an uncharacterized virus from bats (BPgV) (8),
and a recently identified distinct variant infecting horses (EPgV
[Kapoor et al., submitted]). Studies thus far indicate a narrow host
range for these viruses, with HPgV being found only in humans
and chimpanzees, SPgV being found in New World monkeys, and
BPgV and EPgV being found only in bats and horses, respectively
(1). These findings are consistent with the phylogenetic relation-
ships between pegiviruses infecting rodents and other mammalian
species (Fig. 1). Indeed, the two lineages of RPgVs infecting deer
mice (Peromyscus maniculatus) and white-throated wood rats
(Neotoma albigula) are more similar to each other than to pegivi-
ruses found in other mammalian species, an observation that is
consistent with virus-host cospeciation. However, further inves-
tigation of pegiviruses infecting other rodents and mammalian
species will be required to solidify or refute the hypothesis that
pegiviruses are species specific and have codiverged with the evo-
lution of mammals.
The deduced genome organizations of rodent hepaciviruses
and RPgV were similar to those of other members of these genera
(1). The 5= UTRs of RHV and RPgV are long, consistent with the
presence of IRES elements found in other hepaci- and pegiviruses.
In the case of RHV, we were able to model an RNA structure based
on the structurally conserved domains III found in other hepaci-
viruses, providing support for this structure’s function as a type IV
IRES. Interestingly, the RHV 3= UTR elements, but not the pri-
mary sequence, resembled that of HCV, with a putative variable
region immediately downstream of the ORF, followed by a poly-
pyrimidine tract and a 3= X region. However, a short poly(C) tract
replaced the longer poly(U·C) tracts found in HCV isolates. The
RPgV 3= UTR did not have homology to other pegiviruses but,
surprisingly, contained repeat sequence elements (RSEs) identical
to 5= UTR sequences from human enterovirus, coxsackievirus,
echovirus, and swine vesicular disease virus. It is as yet unclear
how RPgV acquired these sequence elements and what function
they might have.
Analysis of the RPgV polyprotein sequences revealed both sim-
ilarities and differences from previously identified pegivirus iso-
lates. Unlike hepaciviruses, pegiviruses typically do not encode a
core (nucleocapsid) protein (26, 27). Nonetheless, biophysical
characterization of HPgV particles suggests the presence of a nu-
cleocapsid, although its origin and composition remain a mystery
(27). The RPgV sequence also lacks a convincing capsid protein
sequence in either the polyprotein-coding or alternative open
reading frames. Rather, the pegivirus polyprotein typically initi-
ates with a signal peptide immediately downstream of the initia-
tion codon that translocates E1 into the ER (position 17 or 21 in
human pegiviruses) (28). For RPgV, this is also the case, but
RPgV-cc61 also possessed an additional 223-residue Y protein
preceding E1, which may be targeted to the ER and glycosylated.
Following the E2 homolog, the RPgV sequence encoded a pre-
dicted, 249-residue-long acidic X protein (Fig. 5), potentially ho-
mologous to, although highly divergent from, those predicted in
EPgV and BPgV (8). RPgV also possesses an additional predicted
signalase site between E2 and NS2 (position 736) that could give
rise to yet another glycosylated membrane protein.
Much of our current knowledge of the replication, host inter-
actions, immune responses, and pathogenesis of HCV and pegi-
viruses comes from experimental infection of primates or cell
culture systems. In vitro models have proven valuable for investi-
gating virus replication (13), yet these systems fail to mimic the
endogenous milieu of the target organ (liver) and may not accu-
rately recapitulate life cycle events, such as polarized cell entry.
Finally, cell culture systems cannot reproduce the interaction be-
tween virus and immune system, nor do they allow for studies of
pathogenesis (12). The identification and genetic characterization
of RHV and RPgV reported here provide a unique opportunity to
develop tractable-animal models to study the infection, transmis-
sion, immunity, and pathogenesis of hepaciviruses and pegivi-
ruses. Although the current study design precluded direct exami-
nation of tissues of infected rodents, it is interesting that the 5=
UTR of RHV contains an miR-122 binding site. These have been
previously described in the HCV 5= UTR (two miR-122 seed sites)
as highly conserved among all genotypes and functionally re-
quired for replication in hepatocytes (29). Similarly, we recently
reported the presence of one miR-122 site in NPHV (7), while the
GBV-B 5= UTR contains sites at positions 8 and 23. Tissue-specific
expression of miR-122 in the liver of vertebrates (including ro-
dents) is consistent with potential hepatotropism of all hepacivi-
ruses identified to date, including RHV. It will be interesting to
define the sites of RHV replication in rodents and NPHV in horses
in future investigations. If RHV does indeed resemble HCV in its
tissue tropism and pathogenesis, rodents could prove to be a very
useful small-animal model. A rodent model for pegivirus infec-
tions is also important for studies focused on the viral and host
factors underlying virus persistence. Estimates suggest that20%
TABLE 1 Amino acid and nucleotide (shaded) sequence divergence of
structural genes (core, E1, and E2) and nonstructural genes (NS2 to
NS5B) between RHV and other hepaciviruses
Genes Virus
% sequence divergence from
indicated virus
RHV HCV NPHV GBV-B
Structural
(core, E1, E2)
RHV 60.8 60.9 57.7
HCV 75.7 52.7 61.8
NPHV 73.9 59.6 61.7
GBV-B 67.2 76.2 75.7
Nonstructural
(NS2 to NS5B)
RHV 57.9 57.1 55.9
HCV 70.4 47.7 58.6
NPHV 69.0 49.6 56.7
GBV-B 65.2 68.1 67.0
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of the world population has been exposed to GBV-C, with chronic
infection established in 1 to 5% of healthy adults (4, 5, 30). Study-
ing RPgV infections in a natural host amenable to genetic manip-
ulation should provide a powerful approach for unraveling mech-
anisms favoring resolved infection versus persistence.
Rodent models also provide an opportunity to investigate
routes of transmission for RPgV and RHV and how this might
relate to HCV transmission, which is due largely to blood-borne
routes of exposure. Such studies performed in rodents, including
deer mice, have been extremely valuable for understanding han-
tavirus transmission (31, 32). Comparative genetic analysis and
functional characterization of viral entry may help to unravel the
determinants of host specificity and tissue tropism and provide
insight into possible routes of cross-species transmission (29, 33).
In addition, defining the natural history of RHV infection, the rate
of chronicity, the immune determinants of clearance and protec-
tion, and possible disease association holds promise for establish-
ing a highly relevant preclinical model for the development of
HCV vaccine strategies and interventions to prevent or reverse
virus-associated liver disease.
MATERIALS AND METHODS
Rodent samples. Plasma samples from rodents of eight species were col-
lected for a program in hantavirus ecology from sites in the southwestern
United States during the period of 2007 to 2009. Samples were stored at
80°C until nucleic acid (NA) extraction. Residual plasma samples were
used in this study and included 43 hispid pocket mice (Chaetodipus hispi-
dus), 9 black-tailed prairie dogs (Cynomys ludovicianus), 9 prairie voles
(Microtus ochrogaster), 9 wood rats (Neotoma cinerea), 4 desert wood rats
(Neotoma lepida), 342 deer mice (Peromyscus maniculatus), 58 white-
FIG 5 (A) Amino acid sequence divergence between RPgV and HPgV, New World primate PgV (SPgV), equine PgV (EPgV), and bat PgV (BPgV) using
300-base fragments by 15-base increments across the sequence alignment (the midpoint is plotted on the y axis). Within-species distances for human and simian
pegiviruses (from New World primates [GBV-A]) are included for comparison. The divergence scan commenced at the predicted signalase cleavage site at the
start of the E1-encoding genes (position 1016). (B, C) Genome diagram of RPgV showing predicted N-linked glycosylation sites (downward-pointing arrows)
and proposed cleavage sites of cellular peptidase (black triangles), NS2-3 protease (white triangle), and NS3-4A protease (gray triangles) (sequence positions were
numbered using the RPgV sequence).
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throated wood rats (Neotoma albigula), 10 western harvest mice (Reithro-
dontomys megalotis), and 9 yellow-pine chipmunks (Tamias amoenus).
High-throughput sequencing (HTS) and generic PCR assays for
hepaciviruses and pegiviruses. Plasma samples were treated with nu-
cleases to digest free NAs for enrichment of viral NA (34–36) and then
extracted in NucliSens buffer using the automated easyMAG system (bio-
Mérieux, United States). NAs were reverse transcribed using Superscript
II reverse transcriptase and converted to double-stranded DNA using the
Klenow fragment (NEB; catalog no. M0212S). Double-stranded DNA
(dsDNA) was fragmented using an Ion Shear Plus reagent kit (catalog no.
4471248). Fragmented dsDNA products were ligated to Ion Xpress adapt-
ers and unique Ion Xpress bar codes (catalog no. 4471250). Bar-coded
libraries were amplified using the Ion Plus fragment library kit (catalog
no. 4471252) and the Ion OneTouch system using the Ion OneTouch 200
template kit (v2, catalog no. 4478316). Sequencing was done with the
Ion Personal Genome Machine (PGM) system by using the Ion PGM
200 sequencing kit (catalog no. 4474004). Two highly degenerate
nested-PCR assays were designed to amplify genetically diverse viruses
related to HCV and HPgV. All PCR mixtures used AmpliTaq gold
360 master mix (Applied Biosystems; catalog no. 4398881) and 3 l of
cDNA. The first degenerate PCR assay used primer pair HGLV-ak1
(5=-TACGCIACNGCIACNCCICC-3=) and HGLV-ak2 (5=-
TCGAAGTTCCCIGTRTANCCIGT-3=) in the first round of PCR and
HGLV-ak3 (5=-GACIGCGACICCICCIGG-3=) and HGLV-ak4 (5=-
TCGAAGTTCCCIGTRTAICCIGT-3=) in the second round of PCR. For
the first round, the PCR cycle included 8 min of denaturation at 95°C, 10
cycles of 95°C for 40 s, 60°C for 1 min, and 72°C for 40 s, 30 cycles of 95°C
for 30 s, 55°C for 45 s, and 72°C for 40 s, and a final extension at 72°C for
5 min. For the second round, PCR conditions included 8 min of denatur-
ation at 95°C, 10 cycles of 95°C for 40 s, 64°C for 1 min, and 72°C for 40 s,
30 cycles of 95°C for 30 s, 57°C for 45 s, and 72°C for 40 s, and a final
extension at 72°C for 5 min. The second degenerate PCR assay used
primer pair AK4340F1 (5=-GTACTTGCTACTGCNACNCC-3=) and
AK4630R1 (5=-TACCCTGTCATAAGGGCRTC-3=) for the first round of
PCR. Primers AK4340F2 (5=-CTTGCTACTGCNACNCCWCC-3=) and
AK4630R2 (5=-TACCCTGTCATAAGGGCRTCNGT-3=) were used in
second round. For the first round, the PCR cycle included 8 min of dena-
turation at 95°C, 10 cycles of 95°C for 40 s, 60°C for 1 min, and 72°C for
40 s, 30 cycles of 95°C for 30 s, 56°C for 45 s, and 72°C for 40 s, and a final
extension at 72°C for 10 min. For the second round, PCR conditions
included 8 min of denaturation at 95°C, 10 cycles of 95°C for 40 s, 64°C for
1 min, and 72°C for 40 s, 30 cycles of 95°C for 30 s, 58°C for 45 s, and 72°C
for 40 s, and a final extension at 72°C for 10 min [6]). 5= UTRs were
determined using rapid identification of 5= cDNA ends (5= RACE) (36). 3=
UTRs were determined by poly(A), -(G), or -(U) tailing of viral RNA
using poly(A) polymerase (USB Affymetrix), followed by reverse tran-
scription using adaptor-containing primers and subsequent PCR ampli-
fication. Thereafter, sequence validity was tested with 4-fold genome cov-
erage by classical dideoxy Sanger sequencing.
Phylogenetic and RNA secondary-structure analysis. Nucleotide se-
quences (5= UTRs) and translated protein sequences (coding regions)
were aligned using the program MUSCLE as implemented in the SSE
package (37). Sequence divergence scans were performed and summary
values for different genome regions were generated by the program Se-
quence Distance in the SSE package. Bootstrapped maximum likelihood
trees for the NS3 helicase region of hepaciviruses and pegiviruses were
generated using RAxML with the PROTGAMMA model (gamma distri-
bution for rates over sites and Dayhoff amino acid similarity matrix with
all model parameters estimated by RAxML) and 100 bootstraps (11). NS3
and NS5B trees for members of all four genera of flaviviruses (Flavivirus,
Pestivirus, Hepacivirus, and Pegivirus) were generated by neighbor joining
of Poisson-corrected pairwise distances.
RNA structures were predicted by Mfold and by homology searching
and structural alignment with bases conserved in other hepaciviruses.
Reliable structure prediction for the pseudoknot region in HCV (IIIf) and
homologous pairings in other hepaciviruses cannot be predicted by Mfold
or other conventional RNA secondary-structure prediction algorithms.
Structure predictions were not attempted upstream of stem-loop III in the
absence of detectable homology to other hepacivirus sequences or com-
parative sequence data from other RHV variants to support covariance or
phylogenetic conservation analysis. Labeling of the predicted structures in
the 5= UTR followed the numbering used for reported homologous struc-
tures in HCV, GBV-B, and NPHV (7). We were unable to predict the
structure the RPgV 5= UTR due to insufficient data for structural align-
ment. Cleavage sites in the RHV polyprotein sequence were predicted for
RHV at sites homologous to those of HCV that have been experimentally
determined. Signalase sites between structural proteins were highly diver-
gent between different hepaciviruses and could not be aligned, therefore
those for RHV and NPHV were independently predicted using the
SignalP version 4.1 program (16) and concordant with positions pre-
dicted from the sequence alignment. RPgV cleavage sites were similarly
predicted by alignment of the NS3/4A, NS4A/4B, NS4B/5A, and NS5A/5B
sites previously proposed for simian pegiviruses (18) and comparison of
SignalP version 4.1 predictions for structural proteins of RPgV and the
NS2/NS3 cleavage site of BPgV (8).
All complete genome sequences were examined for recombination
using the programs Genetic Algorithm Recombination Detection
(GARD) in the DataMonkey package, which provides an interface to the
HyPhy program (38, 39). Default parameters were used with a Hasegawa,
Kishino, and Yano (HKY) substitution model and a gamma distribution
of 6 discrete rate steps. Rodent virus genome sequences were analyzed for
evidence of genome-ordered RNA structures (GORS) by comparing fold-
ing energies of consecutive fragments of nucleotide sequence with ran-
dom sequence order controls using the program’s MFED scan in the SEE
package (37). Minimum folding energies (MFEs) of rodent virus genomes
were calculated by using the default setting in the program Zipfold. MFE
results were expressed as MFEDs, i.e., the percentage difference between
the MFE of the native sequence from that of the mean value of the 50
sequence order-randomized controls (32).
Nucleotide sequence accession numbers. The nucleotide composi-
tions of viruses were determined using EMBOSS compseq (http://emboss
.bioinformatics.nl/cgi-bin/emboss/compseq). All sequences generated in
this study were submitted to GenBank under accession no. KC815310 to
KC815327.
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